The ETS inhibitors YK-4-279 and TK-216 have anti-tumor activity in lymphomas and interfere with SPIB in activated B cell-like type diffuse large B cell lymphoma

ABSTRACT: TMD8 and U2932 were treated with YK-4-279 for 4 and 8 hours.

ORGANISM(S): Homo sapiens

PROVIDER: GSE114022 | GEO | 2021/05/01

REPOSITORIES: GEO